SFM
GRCL
Sphera Funds Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-502,936
| Closed | -$5.05M | – | 112 |
|
|
2023
Q4 | $5.05M | Sell |
502,936
-1,028,561
| -67% | -$10.3M | 0.81% | 44 |
|
|
2023
Q3 | $4.41M | Buy |
1,531,497
+302,832
| +25% | +$872K | 0.8% | 40 |
|
|
2023
Q2 | $4.68M | Sell |
1,228,665
-1,131,915
| -48% | -$4.31M | 0.73% | 46 |
|
|
2023
Q1 | $4.39M | Buy |
+2,360,580
| New | +$4.39M | 0.73% | 44 |
|
|
2021
Q3 | – | Sell |
-233,850
| Closed | -$3.04M | – | 151 |
|
|
2021
Q2 | $3.04M | Buy |
233,850
+21,250
| +10% | +$276K | 0.21% | 77 |
|
|
2021
Q1 | $3.27M | Buy |
+212,600
| New | +$3.27M | 0.25% | 79 |
|